Socio-economic burden of COVID-19 in the Russian Federation

Колбин, А. С.; Белоусов, Д. Ю.; Гомон, Ю. М.; Балыкина, Ю. Е.; Иванов, И. Г.

doi:10.37489/2588-0519-2020-1-35-44

Cited by 8 publications

(6 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A study in the U.S.A showed that Covid-19 coronavirus could result in direct medical costs incurred during the infection from $163.3 billion if 20% of the population gets infected to $654.0 billion if 80% of the population gets infected sensitivity ( 12 ). The results of the sensitivity analysis of a study from Russia showed that the extension of the self-isolation period from 1 month to 1.5 and 2 months will lead to an increase in the share of indirect expenses from 40.65% (1 month) to 56.08 (1.5 months) and 67.76% (2 months) of total expenses in connection with the Covid-19 epidemic ( 9 ). The results of a study showed that the long-term economic burden of the disease could be far higher than the cost of developing and delivering vaccines and effective treatments for the disease ( 30 ).…”

Section: Discussionmentioning

confidence: 99%

“…The results of a study in the U.S.A indicated that approximately 50% of participants reported income and wealth losses due to the coronavirus, with the average losses being $5,293 and $33,482, respectively ( 8 ). A study in Russia showed that the socio-economic burden of Covid-19 would amount to 4.6 trillion rubles ($71.1 billion) or 4 % of GDP ( 9 ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Direct and indirect cost of COVID-19 patients in Iran

Nakhaei

Jalilian

Arab‐Zozani

et al. 2021

Health Policy and Technology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Direct and indirect cost of COVID-19 patients in Iran

Nakhaei

Jalilian

Arab‐Zozani

et al. 2021

Health Policy and Technology

View full text Add to dashboard Cite

“…There were two additional studies "awaiting classification". One we were unable to translate [18] and the other we were unable to obtain the full text [19], even after contacting study authors. See the PRISMA Flow Diagram [10]…”

Section: Literature Searchmentioning

confidence: 99%

Hospitalization costs of coronaviruses diseases in upper-middle-income countries: A systematic review

et al. 2022

View full text Add to dashboard Cite

Background COVID-19, SARS and MERS are diseases that present an important health burden worldwide. This situation demands resource allocation to the healthcare system, affecting especially middle- and low-income countries. Thus, identifying the main cost drivers is relevant to optimize patient care and resource allocation. Objective To systematically identify and summarize the current status of knowledge on direct medical hospitalization costs of SARS, MERS, or COVID-19 in Upper-Middle-Income Countries. Methods We conducted a systematic review across seven key databases (PubMed, EMBASE, BVS Portal, CINAHL, CRD library, MedRxiv and Research Square) from database inception to February 2021. Costs extracted were converted into 2021 International Dollars using the Purchasing Power Parity-adjusted. The assessment of quality was based on the protocol by the BMJ and CHEERS. PROSPERO 2020: CRD42020225757. Results No eligible study about SARS or MERS was recovered. For COVID-19, five studies presented cost analysis performed in Brazil, China, Iran, and Turkey. Regarding total direct medical costs, the lowest cost per patient at ward was observed in Turkey ($900.08), while the highest in Brazil ($5,093.38). At ICU, the lowest was in Turkey ($2,984.78), while the highest was in China ($52,432.87). Service care was the most expressive (58% to 88%) cost driver of COVID-19 patients at ward. At ICU, there was no consensus between service care (54% to 87%) and treatment (72% to 81%) as key burdens of total cost. Conclusion Our findings elucidate the importance of COVID-19 on health-economic outcomes. The marked heterogeneity among studies leaded to substantially different results and made challenging the comparison of data to estimate pooled results for single countries or regions. Further studies concerning cost estimates from standardized analysis may provide clearer data for a more substantial analysis. This may help care providers and policy makers to organize care for patients in the most efficient way.

show abstract

“…В Российской Федерации смертность медиков на период апрель-май 2020 года измерялась от 5 до 6,83%, в значительной мере превышая таковую в других станах: Иране -1,59%; Италии -0,65%; Великобритании -0,53%; США -0,48%; Испании -0,27%; Германии -0,23% [2,5]. По данным другого информационного агентства, на начало сентября 2020 года [6]. Особо необходимо подчеркнуть, что все вышесказанное, демонстрируя актуальность выбранной направленности изучения вопроса реализации ключевых этических позиций с акцентом на медицинский блок, ни в коей мере не умаляет значения всего комплекса логистичес ких усилий политико-экономического характера, а в своей доминанте отражает глобальную и корневую суть проблемы.…”

Section: фокус изучения ключевых этических позиций в условиях пандемиunclassified

Second ethical comments towards COVID-19 (one year later)

Kubar

Бичурина

Romanenkova

2021

Russian Journal of Infection and Immunity

View full text Add to dashboard Cite

At the beginning of COVID-19 development, when social vulnerability in the face of the global infectious threat became obvious, we presented target information on a key civilizational issue — the role of ethics in epidemic emergencies. The compliance of RF legislation and the world ethical standards analyzed on based on the study of the humanitarian heritage of pandemic management and a review of existing international documents. Today, one year later, it is time to practically evaluate the effectiveness of the ideology of ethical commitment and objectively comprehend the conflicts that have arisen, their causes and consequences. It should be emphasized that this work is not a so-called “moral lesson learned from COVID-19”, but representation of a real picture of how the centuries-old experience of former epidemics and pandemics was taken into account and the unique truth of the ethical content of management decisions and actions was accepted. It is particularly important to have a possibility to present this article as a continuation of our research topic on the bioethics of pandemics, on the pages of such an authoritative, specialized journal, which fully allows us to preserve the integrity of ideas about the humanitarian essence of anti-epidemic measures. This humanitarian parallel starts from the moment of managing a particular patient with infectious pathology until large-scale measures for eradication vaccine-preventable diseases. A comprehensive and dynamic look at the need to find ways and the nature of overcoming ethical conflicts during the ongoing pandemic of the new coronavirus infection could determine the ethical approach of longterm recommendations in the field of public health protection and ensure the stability of social trust in the future.

show abstract

Socio-economic burden of COVID-19 in the Russian Federation

Cited by 8 publications

References 7 publications

Direct and indirect cost of COVID-19 patients in Iran

Direct and indirect cost of COVID-19 patients in Iran

Hospitalization costs of coronaviruses diseases in upper-middle-income countries: A systematic review

Second ethical comments towards COVID-19 (one year later)

Contact Info

Product

Resources

About